Privium Fund Management (UK)’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-16,570
Closed -$269K 62
2022
Q2
$269K Buy
+16,570
New +$269K 0.3% 70